{"entity":{"type":"insider","cik":"0001532023","url":"/insider/0001532023","json_url":"/insider/0001532023.json","name":"Gangolli Julian S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":5,"first":"2012-11-29","last":"2024-05-22","span_basis":"filed_date"},"name_variants":[{"name":"Gangolli Julian S","source":"filing","n_filings":5,"first_seen":"2012-11-29","last_seen":"2024-05-22"}],"transactions":[{"id":3184439,"accession":"0001532023-24-000008","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001532023-24-000008","line_url":"/filing/0001532023-24-000008","is_derivative":false,"issuer_cik":"0001532023","issuer_name":"Krystal Biotech, Inc.","issuer_ticker":"KRYS","issuer_name_source":null,"issuer_url":"/issuer/0001532023","owner_cik":"0001532023","owner_name":"Gangolli Julian S","owner_display_name":"Gangolli Julian S","owner_url":"/insider/0001532023","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":164.1344862,"price_display":"164.13","price_state":"stated","total_value":3282689.724,"total_display":"3,282,689.72","total_whole":"3,282,690","shares_owned_after":9070.0,"shares_owned_after_display":"9,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-20","filed_date":"2024-05-22","scope":"insider","n_lines":3},{"id":7879578,"accession":"0000899243-19-013509","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000899243-19-013509","line_url":"/filing/0000899243-19-013509","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001532023","owner_name":"Gangolli Julian S","owner_display_name":"Gangolli Julian S","owner_url":"/insider/0001532023","role":"Officer (President, North America)","role_mark":"O","role_mark_label":"Officer (President, North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, North America","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":671928.0,"shares_display":"671,928","price_per_share":14.84278529842483,"price_display":"14.84","price_state":"stated","total_value":9973283.04,"total_display":"9,973,283.04","total_whole":"9,973,283","shares_owned_after":305916.0,"shares_owned_after_display":"305,916","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-10","filed_date":"2019-05-14","scope":"insider","n_lines":8},{"id":7775328,"accession":"0000899243-19-005266","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-005266","line_url":"/filing/0000899243-19-005266","is_derivative":false,"issuer_cik":"0001351288","issuer_name":"GW PHARMACEUTICALS PLC","issuer_ticker":"GWPH","issuer_name_source":null,"issuer_url":"/issuer/0001351288","owner_cik":"0001532023","owner_name":"Gangolli Julian S","owner_display_name":"Gangolli Julian S","owner_url":"/insider/0001532023","role":"Officer (President, North America)","role_mark":"O","role_mark_label":"Officer (President, North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, North America","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":12.44936,"price_display":"12.45","price_state":"stated","total_value":74696.16,"total_display":"74,696.16","total_whole":"74,696","shares_owned_after":106596.0,"shares_owned_after_display":"106,596","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-26","filed_date":"2019-02-28","scope":"insider","n_lines":2},{"id":4498219,"accession":"0001127602-13-035791","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001127602-13-035791","line_url":"/filing/0001127602-13-035791","is_derivative":false,"issuer_cik":"0000850693","issuer_name":"ALLERGAN INC","issuer_ticker":"AGN","issuer_name_source":null,"issuer_url":"/issuer/0000850693","owner_cik":"0001532023","owner_name":"Gangolli Julian S","owner_display_name":"Gangolli Julian S","owner_url":"/insider/0001532023","role":"Officer (CVP & Pres, North America)","role_mark":"O","role_mark_label":"Officer (CVP & Pres, North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP & Pres, North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52500.0,"shares_display":"52,500","price_per_share":110.04857142857144,"price_display":"110.05","price_state":"stated","total_value":5777550.0,"total_display":"5,777,550.00","total_whole":"5,777,550","shares_owned_after":8047.202,"shares_owned_after_display":"8,047.20","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-27","filed_date":"2013-12-30","scope":"insider","n_lines":2},{"id":2487497,"accession":"0001127602-12-032319","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001127602-12-032319","line_url":"/filing/0001127602-12-032319#line-5","is_derivative":false,"issuer_cik":"0000850693","issuer_name":"ALLERGAN INC","issuer_ticker":"AGN","issuer_name_source":null,"issuer_url":"/issuer/0000850693","owner_cik":"0001532023","owner_name":"Gangolli Julian S","owner_display_name":"Gangolli Julian S","owner_url":"/insider/0001532023","role":"Officer (CVP & Pres, North America)","role_mark":"O","role_mark_label":"Officer (CVP & Pres, North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP & Pres, North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55378.0,"shares_display":"55,378","price_per_share":91.66,"price_display":"91.66","price_state":"stated","total_value":5075947.48,"total_display":"5,075,947.48","total_whole":"5,075,947","shares_owned_after":15780.637,"shares_owned_after_display":"15,780.64","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-28","filed_date":"2012-11-29","scope":"insider"},{"id":2487487,"accession":"0001127602-12-032319","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001127602-12-032319","line_url":"/filing/0001127602-12-032319#line-3","is_derivative":false,"issuer_cik":"0000850693","issuer_name":"ALLERGAN INC","issuer_ticker":"AGN","issuer_name_source":null,"issuer_url":"/issuer/0000850693","owner_cik":"0001532023","owner_name":"Gangolli Julian S","owner_display_name":"Gangolli Julian S","owner_url":"/insider/0001532023","role":"Officer (CVP & Pres, North America)","role_mark":"O","role_mark_label":"Officer (CVP & Pres, North America)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CVP & Pres, North America","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34622.0,"shares_display":"34,622","price_per_share":92.2533,"price_display":"92.25","price_state":"stated","total_value":3193993.7526,"total_display":"3,193,993.75","total_whole":"3,193,994","shares_owned_after":15780.637,"shares_owned_after_display":"15,780.64","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-11-27","filed_date":"2012-11-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001711279","name":"Krystal Biotech, Inc.","url":"/issuer/0001711279","role":"Director","n_filings":1,"first_seen":"2024-05-22","last_seen":"2024-05-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001351288","name":"GW PHARMACEUTICALS PLC","url":"/issuer/0001351288","role":"Officer (President, North America)","n_filings":2,"first_seen":"2019-02-28","last_seen":"2019-05-14"},{"type":"issuer","type_label":"ISSUER","cik":"0000850693","name":"ALLERGAN INC","url":"/issuer/0000850693","role":"Officer (CVP & Pres, North America)","n_filings":2,"first_seen":"2012-11-29","last_seen":"2013-12-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001532023","retrieved_at":"2026-08-25T08:13:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}